|Bid||59.70 x 1000|
|Ask||60.83 x 900|
|Day's Range||60.10 - 61.84|
|52 Week Range||44.79 - 90.19|
|Beta (5Y Monthly)||0.56|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 03, 2021 - Aug 09, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||97.00|
If you want to know who really controls Arena Pharmaceuticals, Inc. ( NASDAQ:ARNA ), then you'll have to look at the...
Arena Pharmaceuticals announced the Company earned Prime status from the ISS ESG Corporate Rating, the industry standard for sustainable investing.
Arena Pharmaceuticals (ARNA) beats Q1 bottom-line estimates. The company progresses with the development of its key pipeline candidate, etrasimod.